Genomics-Driven Precision Medicine for Advanced Pancreatic Cancer: Early Results from the COMPASS TrialKyaw Aung, Jennifer J. Knox, Grainne M. O’Kane et al.|Clinical Cancer Research|2017Cited by 635
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriersTalia Golan, Steven Gallinger, Zaheer Kanji et al.|British Journal of Cancer|2014Cited by 437
Germline <i>BRCA</i> Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic AdenocarcinomaSpring Holter, Steven Gallinger, Ayelet Borgida et al.|Journal of Clinical Oncology|2015Cited by 396
Recommendations for a More Organized and Effective Approach to the Early Detection of Pancreatic Cancer From the PRECEDE (Pancreatic Cancer Early Detection) ConsortiumTamas A. Gonda, George Zogopoulos, Jessica N. Everett et al.|Gastroenterology|2021Cited by 42
Standardization of EUS imaging and reporting in high-risk individuals of pancreatic adenocarcinoma: consensus statement of the Pancreatic Cancer Early Detection ConsortiumTamas A. Gonda, Rosalie C. Sears, James J. Farrell et al.|Gastrointestinal Endoscopy|2021Cited by 27